Back to search
FDAFDA · Food and drugs·Recall number Z-0734-2014

Oxoid Antimicrobial Susceptibility Testing Disc, MEM10, REF: CT0774B, 10 mcg meropenem, Packed in packs containing 5 cartridges per pack, 50 discs per cartridge. Firm name on the label is Oxoid, Ltd., Basingstoke, United Kingdom. Used in the semi-quantitative agar diffusion test method for in vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes.

Published January 22, 2014 · Recall initiated: November 21, 2013

Summary

FDA records medical device Class II recall Z-0734-2014, published January 22, 2014 and initiated November 21, 2013. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 45/5/50 - discs/cartridges/packs; Lot: Lot number: 1223566 EXP: 8/31/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Individual discs in the lot may not be sufficiently impregnated with antibiotic, resulting in smaller than expected zone sizes.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Nationwide Distribution including the states of AL, AZ, CA, CO, FL, HI, IA, IL, KY, LA, MD, MI, MN, MO, MS, NC, NY, OH, SC, TN, TX, VA, WI, and WV
Lot
Lot number: 1223566 EXP: 8/31/2013
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Oxoid Antimicrobial Susceptibility Testing Disc, MEM10, REF: CT0774B, 10 mcg meropenem, Packed in packs containing 5 cartridges per pack, 50 discs per cartridge. Firm name on the label is Oxoid, Ltd., Basingstoke, United Kingdom. Used in the semi-quantitative agar diffusion test method for in vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes. recalled?

Yes. FDA published recall Z-0734-2014 on January 22, 2014. Reported hazard: Individual discs in the lot may not be sufficiently impregnated with antibiotic, resulting in smaller than expected zone sizes.

What should I do if I have this product?

Voluntary: Firm initiated · Letter